LSD1 has been found to be overexpressed in a variety of cancers, including breast cancer, liver cancer and tongue cancer, and its expression status is correlated with its oncogenic effects in tumorigenesis (52–54). This evidence concerns the gene KDM1A and breast carcinoma.